Bacteria capable of growth on methane and a variety of complex organic substrates as sole sources of carbon and energy have been isolated. Conditions used to rigorously establish the purity of the cultures are described. One facultative methylotroph has been studied in detail. This organism has peripherally arranged pairs of intracytoplasmic membranes characteristic of obligate methylotrophs. This isolate apparently utilizes the serine pathway of formaldehyde fixation. The location of methane oxidizers in a dimictic lake indicates that these organisms prefer less than saturating levels of dissolved oxygen. Laboratory experiments confirmed the preference of these organisms for atmospheres containing less oxygen than air. One of these isolates has been more fully characterized and is described. (The work described in this paper was submitted to the University of Wisconsin by G. C. C. and T. E. P. in partial fulfillment of the requirements for the M.S. degree.) MATERIALS AND METHODS Organisms. Methylosinus sporium 12 and Methylosinus trichosporium PG were used in some experiments for comparison with our isolates (31). These organisms were kindly provided by R. Whittenbury, 955
In screening for newantifungal agents from fungi, a new lipopeptide antifungal agent, L-671,329, similar to echinocandin B, has been isolated from Zalerion arboricola. Studies indicate that L-671 ,329 is produced under both solid and liquid fermentation conditions. Echinocandins/aculeacins are lipopeptide antifungal agents. The polar, cyclic hexapeptide portion of these compoundsis structurally unusual in that all the amino acids contain one or more hydroxyl groups. In sharp contrast to the peptide portion is the extremely non-polar, fatty side chain, which is amide-linked to the amino group of an ornithine-derived amino acid residue^. Variation has been observed in both the cyclic peptide (hydroxylation and amino acid substitution patterns)2'^and in the lipophilic side chain (length, branching, and degrees of unsaturation)3>4).The antibiotic activity of echinocandins appears to be limited to yeasts, especially Candida sp.5). While both natural2~4) and chemical6) variation of the echinocandin structure have shown that the biological activity can be manipulated via structural modification, enzymatic removal of the fatty side chain has shown that the cyclic peptide is inactive alone7), as is the fatty acid. LY121019, a semisynthetic derivative of echinocandin B which showed good in vitro and in vivo anti-Candida activity, was reported to be at least 20-fold less toxic than amphotericin B and, therefore, promises to be important in treating these types of infections in the clinic8).In this paper the fermentation and isolation of L-671,329, a new echinocandin, will be discussed; in the following papers the structural elucidation9) and biological activities10) of this compound will be described. Materials and MethodsThe methods of detection utilized in the following studies and isolations were antifungal activity as measuredvia zones of inhibition in a disc diffusion assay on agar plates seeded with Candidaalbicans (MY 1028), Merck Culture Collection, HPLCon C18 reversed-phase, or both.Antifungal Assays Seeded agar plates were prepared as follows. Potato dextrose broth (50 ml, Difco) was inoculated with a lyophilized pellet of C. albicans, and the culture was incubated for 24 hours at 28°C, with agitation at 220 rpm. This culture was used as a 1 %inoculum to seed potato dextrose agar (PDA, Difco). Assay samples (20^1) were applied to 6.2 mm-filter discs and air dried at room temperature before being placed on the seeded assay plates. After incubation at 28°C for 24 hours, zones of inhibition were measured via image analysis from the extreme edges of clearing against the background lawn, A standard curve was generated using compoundL-671,329. The critical variation of standard concentrations ranged from 3~8 %.
Erythromycin-and clindamycin-resistant Corynebacterium diphtheriae isolates were recovered from skin lesions. Resistance to erythromycin and clindamycin was induced by a subinhibitory concentration (0.03 usg/ml) of erythromycin. Clindamycin (0.07 ,ug/ml) was a more effective inducer of its own resistance than of erythromycin resistance. Erythromycin-inducible cross-resistance to vemamycin B. was demonstrated in disk diffusion tests.Erythromycin had been considered the drug of choice for diphtheria patients in Seattle since an epidemic began in 1972 (11); however, resistance to erythromycin and clindamycin was recently found in Corynebacterium diphtheriae isolated from 7 of 30 patients with cutaneous diphtheria. All of the resistant isolates were nontoxigenic biotype mitis. Five of the patients had received erythromycin for previous diphtheria infections, but none had received this drug during the 4 months before recovery of resistant isolates from their skin lesions. This is the first report of erythromycin-resistant C. diphtheriae in the United States, although resistant isolates have been reported from Canada (5). Inducibility of resistance of these C. diphtheriae isolates is the subject of this report.Cultures were grown in brain heart infusion broth (Difco Laboratories, Detroit, Mich.) supplemented with 0.2% Tween 80 (Sigma Chemical Co., St. Louis, Mo.) to enhance growth (9). Mueller-Hinton agar (Difco) supplemented with 5% sheep blood was used for disk susceptibility tests and for determinations of minimal inhibitory concentrations (MICs) of antibiotics. Susceptibility tests were performed by standardized methods (10, 13). A Steers replicator (12) Erythromycin-resistant C. diphtheriae from seven patients and a susceptible quality control strain, QC-100 biotype mitis, were tested for their antibiotic susceptibilities. In disk diffusion tests, erythromycin-resistant isolates (zone diameters, 9 to 10 mm) were also resistant to clindamycin (6-mm zones). The susceptible quality control strain developed zones of inhibition of 35 and 28 mm around erythromycin and clindamycin disks, respectively. All isolates were resistant to oxacillin (6-mm zone) but susceptible to other antibiotics routinely tested with gram-positive bacteria.Agar dilution MICs for erythromycin and clindamycin confirmed the result of disk diffusion tests. The erythromycin MICs for the resistant isolates ranged from 32 to 256 ,ug/ml, and the clindamycin MICs were >512 ,ug/ml. The susceptible strain, QC-C100, was inhibited by <0.015 ,ug of erythromycin per ml and 0.06 ,ug of clindamycin per ml. Induction to a higher level of erythromycin resistance was observed in the resistant isolates when the inocula for the agar MIC tests were pregrown in a subinhibitory concentration of erythromycin (0.07 ,ug/ml). The erythromycin MICs of the induced cultures were increased to >512 ug/ml. Since both induced and uninduced cultures grew on MIC plates containing the highest concentration of clindamycin tested (512 ,ug/ml), the agar MIC tests could not detect in...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.